2010 Medicines in development for Women.pdf

《2010 Medicines in development for Women.pdf》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、200R9eportMEDICINESINDEVELOPMENTFORWomenPRESENTEDBYAMERICA’SPHARMACEUTICALRESEARCHCOMPANIESNearly1,000MedicinesAreinTestingforDiseasesofMajorConcerntoAmericanWomenmerica’spharmaceuticalresearchandbiotech-MedicinesandVaccinesinDevelopmentforWomen*nologyco

2、mpaniesaredeveloping969medicinesAfordiseasesthatdisproportionatelyaffectAmericanwomen.Themedicinesinthepipelineforwomen(eitherinclinicaltrialsorawaitingapprovalfromtheFoodandDrugAdministration)include:•163forfemalespecificcancers,including112forbreastcan

3、cer,62forovariancancer,and14forcervicalcancer.•131forarthritis/musculoskeletaldisorders.Arthritisaffects41millionwomen,accountingfor70percentofallrheumatoidarthritissufferersandnearly59percentofAmericanswithosteoarthritis.•86forobstetric/gynecologiccondi

4、tions.•114forautoimmunediseases,whichstrikewomenthreetimesmorethanmen.•155fordiabetes,whichisreachingepidemicproportions,particularlyamongwomenandminorities.*Somemedicinesarelistedinmorethanonecategory.Morethan11millionwomenovertheageof20havediabetes,inc

5、ludingone-fourthwhodonotknowit.Inseparatereports,PhRMAhasfoundthatresearchersareworkingon312medicinesforheartdiseaseand•74fordepressionandanxiety.Almosttwiceasmanystroke—whichkillnearlyhalfamillionwomeneachwomenasmensufferfromthesedisorders.year—and122me

6、dicinesforlungcancer,theleading•80forAlzheimer’sdisease.In2006,morethancancerkillerofwomen(seepage66fordetails).70percentofAlzheimer’sdeathswerewomen.America’spharmaceuticalresearchandbiotech-•76forasthma,whichaffectednearly23millionnologycompaniescontin

7、uemakingexcitingprogressinAmericansin2007,withtheprevalencerateforthesearchfornewcuresandtreatmentsfordiseasesofwomenbeing36percenthigherthanformen.specialconcerntowomen.WeliveinanerainwhichAmongthepotentialnewmedicinesindevelopmentweunderstandevermoreab

8、outthedifferencebetweenforwomen:thesexesandtheirhealthcareneeds.Thisknowledgeisinspiringacontinuingmedicalrevolutionthatisbringing•Afirst-in-classmedicineindevelopmentfortype2newhopetowomenaroundtheworld.diabetesshownincli